High virologic response rate after second-line boosted protease inhibitor-based antiretroviral therapy regimens in children from a resource limited setting

by Puthanakit T., Jourdain G., Suntarattiwong P., Chokephaibulkit K., Siangphoe U., Suwanlerk T., Prasitsuebsai W., Sirisanthana V., Kosalaraksa P., Petdachai W., Hansudewechakul R., Waranawat N., Ananworanich J., Bunupuradah T., Phasomsap C., Kaew-on P., Kanjanavanit S., Hinjiranandana T., Layangool P., Kamonpakorn N., Buranabanjasatean S., Ngampiyaskul C., Chotpitayasunondh T., Chanpradub S., Leawsrisuk P., Chearskul S., Vanprapar N., Phongsamart W., Lapphra K., Chearskul P., Wittawatmongkol O., Intalapaporn K., Kongstan N., Pannin N., Maleesatharn A., Khumcha B., Aurpibul L., Wongnum N., Nadsasarn R., Lumbiganon P., Tharnprisan P., Udompanich T., Yentang M., Khonponoi A., Maneerat N., Denjunta S., WatanapornS., Yodsuwan C., Srisuk W., Somsri S., Surapanichadul K.
Published 2014